Related by context. All words. (Click for frequent words.) 79 Antitrust Improvements Act 76 HSR Act 71 Antitrust Improvement 69 HSR Antitrust Improvements 61 HSR Waiting Period 57 customary regulatory approvals 56 customary closing 56 customary closing conditions 56 antitrust clearance 55 premerger notification 54 applicable regulatory approvals 53 Announce Early Termination 53 stockholder approvals 53 shareholder approvals 52 Exon Florio 52 regulatory clearances 52 Granted Early Termination 52 consents authorizations 51 stockholder approval 51 Receives Early Termination 51 regulatory approvals 49 Merger Agreement 49 Waiting Period 48 Proposed Merger 48 regulatory approval 48 Announces Early Termination 47 Proposed Acquisition 47 Merger Regulation 47 requisite regulatory approvals 47 Financing Condition 47 definitive documentation 47 Stock Purchase Agreement 46 jurisdictional thresholds 46 definitive agreement 46 Premerger Notification 46 tender offer 46 HSR clearance 45 premerger 45 Pending regulatory approvals 45 Stockholders Approve Merger Agreement 45 definitive agreements 45 Announce Expiration 45 Confirms Receipt 45 Definitive Proxy Statement 45 Cellu Tissue stockholders 45 Inducement Stock 45 Accredo Health Incorporated 44 Definitive Merger Agreement 44 definitive merger 44 Shareholder Approval 44 Shelf Prospectus dated 44 Underwriters Exercise 44 Stockholder Approval 44 Extends Tender Offer 44 Requisite Consents 44 PNBK Holdings LLC 44 Acquisition Transaction 44 Receives NASDAQ 44 requisite approvals 44 satisfactory due diligence 44 Stockholders Approve Merger 44 Merger Transaction 44 Proposed Transactions 44 mutually acceptable definitive 44 Arrangement Agreement 44 Merger 44 Unsolicited Proposal From 44 Securities Purchase Agreement 44 Announce Shareholder Approval 44 Inc. Nasdaq CVTX 44 valid acceptances 43 antitrust regulators 43 Exploring Strategic Alternatives 43 confirmatory due diligence 43 NYSE MRX 43 Regains Compliance 43 Thermadyne shareholders 43 Proposed Financing 43 Consummation 43 concurrent consent solicitations 43 Explores Strategic Alternatives 43 Asset Purchase Agreements 43 NASDAQ CHIP VeriChip 43 Unsolicited Tender Offer 43 Acquisition 43 Share Purchase Agreement 43 ReAble Therapeutics Inc. 43 Receives Notification From 43 NASDAQ NHWK 43 Tender Offer 43 Director Shareholding 43 OTCBB LEVP 43 Proposed Combination 43 Cease Trade Orders 43 Amend Merger Agreement 43 Recapitalization Agreement 43 License Option Agreement 43 Pending Acquisition 43 Regulatory Approvals 43 Proposed Buyout 43 Terminate Merger Agreement 43 NASDAQ THMD 43 Nasdaq EPCT 42 Required Documents 42 Merger Sub 42 Nasdaq Listing Requirements 42 Metabasis stockholders 42 CFIUS 42 Investigational Device Exemption 42 requisite consents 42 Acquisition Sub 42 Drug Submission 42 Nasdaq Delisting Notification 42 Business Combination 42 TSX PLB leading 42 Binding Offer 42 JHP Pharmaceuticals LLC 42 necessary regulatory approvals 42 lender consents 42 MQ Associates 42 thecompletion 42 Nasdaq MGRM 42 Expiration Time 42 Merger Agreement dated 42 consent decree lodged 42 Combination Agreement 42 Acknowledges Receipt 42 Inc. NASDAQ OSTE 42 Announce Receipt 42 reincorporation merger 42 Shelf Registration Statement 42 Announces Stockholder Approval 42 Shareholder Investigation 42 Terminates Merger Agreement 42 Receives Notification 42 Nasdaq MYL 42 NASDAQ Listing 42 PLLL Acquisition Co. 42 Late Filing 42 NASDAQ XETA 42 Minimum Tender 42 theSecurities 42 Board Unanimously Rejects 42 shares issuable pursuant 42 Identive Group Nasdaq INVE 42 GLBA Reg P 42 Debt Tender Offer 42 Schedule #C 42 le Societa e 42 CORLUX CORT # 42 initiate delisting 41 Nasdaq COGT 41 Axcan Pharma Holding BV 41 Abe Shainberg Esq 41 Schedule #A 41 Securityholders Approve 41 requisite stockholder 41 Trubion stockholders 41 Zolpidem Tartrate Tablets 41 Amalgamation Agreement 41 Debt Settlement Agreements 41 Graphic Packaging Corporation 41 unitholder approval 41 CCI Pellet Agreements 41 NASDAQ IMDC 41 Continued Listing 41 CBay Holdings 41 Terminates Agreement 41 Fiduciary Duty 41 Consent Time 41 Proposed Transaction 41 Regains Full 41 Proposed Qualifying Transaction 41 Share Repurchase 41 Inc. NASDAQ CVTX 41 warrantholders 41 Termination Agreement 41 Due Diligence Period 41 Alkaloida 41 Receives Favorable 41 Unsolicited Proposal 41 Announces Definitive Merger 41 Completes Tender Offer 41 Amended Offer 41 Investigates Possible Breach 41 Nasdaq WCRX 41 Investigates Proposed Acquisition 41 Market Authorization Application 41 NASDAQ BRKL 41 Shareholders Approve Merger Agreement 41 Antitrust Clearance 41 Rozetta Cell 41 Regarding Proposed Acquisition 41 Shareholder Opposes 41 NASDAQ Deficiency Notice 41 severe hypercholesterolemia 41 Second Tranche 41 remaining untendered 41 AMEX IVX LSE IVX.L 41 validly deposited 41 Xenith Corporation 41 Share Repurchase Program 41 BGH GP Holdings 41 Supplemental Indentures 41 NASDAQ MOGN 41 LQU 41 submitted supplemental Biologics 41 Shareholders Approve Proposed 41 NYSE MIM MID 41 NASDAQ Listing Requirements 41 Finansinspektionen 41 Begins Tender Offer 41 Asset Purchase Agreement 41 Adopts Stockholder Rights 41 Early Settlement Date 41 valuations thereof 41 Schedule #D 9 41 Files Registration Statement 41 NYSE AGO Assured 41 please visit www.innercool.com 41 Files Shelf Registration Statement 41 Shareholder Vote 41 Extends Expiration 41 Consummates 41 Announces Tentative Approval 40 TechTeam Global stockholders 40 CCU Notes 40 pediatric exclusivity 40 Successfully Completes Tender Offer 40 Revised Proposal 40 Regains NASDAQ 40 TRUSTCASH 40 Closes Merger 40 NASDAQ Listing Qualifications 40 Approve Merger 40 Signs Merger Agreement 40 symbol CYTC 40 EnPro Industries Announces 40 Biologic License Application 40 Acquisition Proposal 40 Investigates Breach 40 mutually satisfactory definitive 40 Susquehanna NASDAQ SUSQ 40 Stockholders Reject 40 Acquisition Agreement 40 Stockholder Rights Plan 40 Voluntary Delisting 40 NASDAQ PSYS 40 Proposed Arrangement 40 Commences Mailing 40 CommScope stockholders 40 securityholder approval 40 Previously Announced 40 Combination Transaction 40 Financing Transactions 40 specify Kirrin News 40 Takeover Bid 40 Makes Unsolicited Bid 40 OTCBB BNGOF 40 Merger Agreement pursuant 40 PVC Additives 40 Arigene 40 Ravelston Entities 40 ANDA abbreviated 40 Debt Refinancing 40 Nasdaq Deficiency Notice 40 rStar 40 Merger Sub pursuant 40 Provides Update Regarding 40 Nasdaq Delisting 40 CEFF financings subject 40 Securities andExchange Commission 40 FIRB approval 40 securityholder approvals 40 Lebowa transaction 40 IND Investigational New 40 Falconbridge Acquisition 40 Pharmachem Revised Offer 40 Aeroflex stockholders 40 Minimum Tender Condition 40 Adamis Pharmaceuticals Corporation 40 Form 8K 40 Receives Stockholder Approval 40 NitroMed BiDil 40 validly tendered 40 OTCBB BTEM 40 Articles Supplementary 40 Successfully Completes Acquisition 40 Proposed Takeover 40 SEBI Substantial Acquisition 40 Nasdaq ARST 40 NASDAQ LBTYA NASDAQ LBTYB 40 NASDAQ CYBS 40 Receives Approvals 40 Announce Merger Agreement 40 NASDAQ MERX 40 GHL Acquisition stockholders 40 Regains Nasdaq 40 Debenture Financing 40 KIF6 Genotyping Assay 40 Consenting Noteholders 40 Formal Agreements 40 Corp. Nasdaq TLCR 40 Manges LLP acted 40 PLLL Holdings LLC 40 Completes Debt Refinancing 40 Completes Previously Announced 40 Takeover Offer 40 Preliminary Proxy Statement 40 Common Stock Repurchase 40 Recapitalization Transaction 40 TriPath Oncology 40 Stockholders Approve 40 Files Annual Report 40 Securities Purchase Agreements 40 MR Civ 40 Federal Cartel 40 execute supplemental indenture 40 Regains Compliance With 40 BNY Mellon Appointed 40 antitrust 40 FDA Approvable Letter 40 SkyTerra Communications Inc. 40 Cash Tender Offers 40 Gramm Leach Bliley GLB 40 Humanitarian Device Exemption 40 NETM 40 Proginet stockholders 39 Inc. NASDAQ BMET 39 TASE XTL 39 Endures Analyst Downgrade 39 Debt Tender Offers 39 LCE Holdings 39 Federal Trade 39 Stockholder Protection 39 Complete Merger 39 Inc. NASDAQ CLRT 39 ECMV 39 tendered pursuant 39 Welcomes Analyst Initiation 39 Company NYSE KWD 39 Auction Tender Offer 39 antitrust enforcers 39 Announces Consummation 39 acquiror 39 Attracting Bullish Investors 39 Pending Merger 39 Z5 Technologies 39 Commence Trading 39 Nasdaq HRLY 39 Announces Postponement 39 Submits Revised 39 transactions contemplated 39 EGI Acquisition LLC 39 Warrantholders 39 Escrow Release Conditions 39 Offerors Commercial applies 39 NQCI 39 Consent Fees 39 OTCBB NVDL 39 Nasdaq CLZR 39 Notification Related 39 National Dentex 39 Equity Inducement 39 AMEX AOM 39 Inc. Nasdaq NHRX 39 Graham Leach Bliley 39 Equitex 39 ReAble 39 Subsequent Offering 39 Inc. AMEX OKN 39 Wolf Haldenstein Investigates 39 governmental approvals 39 ticker LUPE 39 Extends Expiration Date 39 Special Stockholder Meeting 39 Consent Payment Deadline 39 file Form #b 39 Stock Repurchase Plan 39 Nasdaq CLDX 39 NYSE Amex LBY 39 TSX IEX 39 FRANKLIN Tenn. Business Wire 39 Shareholder Claims 39 Consent Solicitations 39 Stock Buyback 39 Unefon Holdings 39 Completes Reorganization 39 Files Investigational 39 Shareholders Approve Acquisition 39 QMLP 39 Cobalt Pharmaceuticals 39 Nasdaq Delisting Notice 39 consummation 39 k premarket 39 Accelerated Share Repurchase 39 Fistel LLC Announces 39 MSc Qualified Person 39 Crane Merger Sub 39 Early Tender Consent Deadline 39 SOX Sarbanes Oxley 39 Seek Shareholder Approval 39 Nasdaq Minimum Bid 39 thetransaction 39 Purported Class 39 Rejects Unsolicited 39 Schedules Investor 39 Definitive Agreements 39 Wolf Haldenstein Investigating 39 USEB Chapter 39 FAR #.#-# Instructions 39 Nasdaq SMTS develops manufactures 39 Share Repurchase Plan 39 validly tendered Notes 39 Reports Inducement Grants 39 Sets Earnings Release 39 NASDAQ GYMB 39 Stockholders Approve Acquisition 39 Completes Buyout 39 Definitive Purchase Agreement 39 Standby Purchase Agreement 39 Nasdaq SMTS 39 Announces Revocation 39 Evaluate Strategic Alternatives 39 Announce Successful Completion 39 DASA Finance 39 Tommy Hilfiger BV 39 Earnings Postmortem 39 NASDAQ COGT 39 OTCBB FROI 39 NASDAQ TONS 39 Required Filings 39 Option Grants 39 MarkWest Hydrocarbon 39 Announces Adjournment 39 TAXUS Element Stent System 39 International NYSE VRX 39 Settle Litigation 39 Unitholders Approve 39 Balance Sheet Restructuring 39 Application BLA 39 Valeant unsolicited 39 Shareholders Approve Merger 39 Takeover Code 39 Versatel Telecom International 39 supplemental Biologics License Application 39 Amended Merger Agreement 39 Subscription Receipt Agreement 39 Inc. Nasdaq TRMA 39 Offer Prospectus 39 commenced consent solicitation 39 Kaneb Partners 39 Receives Unsolicited 39 Restated Agreement 39 NASDAQ WVCM 39 ZEGERID Chewable Tablets 39 Denmark Holding ApS 39 Billion Buyout 39 transaction 39 Reincorporation 39 Possible Breaches 39 MONSTERSTOX.COM Monsterstox.com 39 Superior Proposal 38 Offeror 38 wholly ownedsubsidiary 38 Arrangement Resolution 38 Extends Offer 38 Merger Approved 38 NASDAQ ENZN 38 AMPS Risk 38 Offer Period 38 commercialize telaprevir 38 dedicated CHAT ROOM 38 redomiciliation 38 consent solicitations 38 Inc. OTCBB EBOF 38 Cardiogenesis Corporation 38 Nasdaq Notice Regarding 38 Registration Statement Declared Effective 38 Omnibus Incentive Plan 38 PLIVA dd 38 TKH Group 38 daily Glumetza TM 38 Consent Expiration Date 38 Inc. NASDAQ NETM 38 Inc. NASDAQ GETI 38 Announces Effectiveness 38 AMEX OTD 38 NASDAQ CLZR 38 MURRIETA CA #/#/# 38 Enters Into Merger Agreement 38 Biologics License Application 38 Form 8K filed 38 Early Termination 38 FDA approvable letter 38 share repurchase authorization 38 Previously Disclosed 38 Premarket Approval Application 38 Miscellaneous Fares 38 Trico Shipping 38 Lumera stockholders 38 Repurchase Program 38 Acceptance Date 38 Its Previously Announced 38 Subsidiary Enters 38 Shelf Registration 38 novel MetAP 2 38 AMFM Notes 38 GTC NASDAQ GTCB 38 vinorelbine emulsion 38 DTV Delay 38 Shareholders Approve Plan 38 WSE IVX 38 Q2 Adj 38 Marketing Authorisation Application 38 Spin Off Transaction 38 Vector Intersect 38 Inc. NASDAQ INTV 38 DIP Financing 38 TSX DEJ announces 38 exemptive relief 38 Valeant Pharma 38 Valitás 38 thus unlawfully harming 38 filed Solicitation Recommendation 38 Inc. NYSE CZR 38 Corporation OTCBB SVUL 38 Compulsory Acquisition 38 Derivative Action 38 soliciting consents 38 CapGen Offering 38 Approve Acquisition 38 authority NMa 38 Waiver Agreement 38 BiDil XR drug 38 Completes Asset 38 Dycom Investments 38 Antitrust Division 38 GTC Nasdaq GTCB 38 NRDC Acquisition 38 Performance Incentive Plan 38 Firdapse ™ amifampridine phosphate 38 NASDAQ BORL 38 Valera Pharmaceuticals Inc. 38 received CE Conformite 38 Topiramate Tablets 38 Teksid Luxembourg 38 Revised Offer 38 CEMATRIX 38 symbol HAWK 38 Consent Agreement 38 Consent Letter 38 Goes Hostile 38 NASDAQ Minimum Bid 38 Euronext GLPG 38 Board Authorizes 38 Directors Unanimously Rejects 38 Kaneb Services 38 Announces Underwriters Exercise 38 NASDAQ ACDO 38 Clinical Trial Application 38 indentures pursuant 38 Holders Approve 38 Contingent Value Right 38 Declares Regular Quarterly 38 Mutually Agree 38 NewsBite Downgrade Puts Pressure 38 Gestiva TM 38 Public Utilities Commissions 38 Nasdaq PPCO 38 Recapitalization Plan 38 NASDAQ CGRB 38 Transactions FACT 38 Common Criteria Recognition 38 merger 38 telavancin NDA 38 DIP financing facility 38 Underwriting Agreement 38 TSX VENTURE BRI 38 Announces Mailing 38 Proposed Amalgamation 38 Qinnan PSC 38 Nasdaq IMDC 38 CNPCI 38 Adopts Poison Pill 38 Executes Binding 38 NASDAQ MOVI 38 Exclusivity Period 38 subsidiary WGL Entertainment 38 filedwith 38 Rights Plan 38 Complete Liquidation 38 Kyowa Pharmaceutical Industry 38 NASDAQ CPEX 38 Medicis Inamed 38 Employment Inducement Award 38 eXegenics 38 Substantial Issuer Bid 38 eprodisate KIACTA TM 38 CEO Exercises Options 38 symbol TSH 38 visit smith.com 38 NSE SUNPHARMA 38 Causes Shareholder 38 prospectus proxy 38 Neurogen stockholders 38 TSX VENTURE SPQ Spider 38 visit www.c cor.com 38 rapid thyroid stimulating 38 ANY SUCH DOCUMENTS FILED 38 Edgen Corporation 38 Shareholders Overwhelmingly Approve 38 Private Securities Reform Act 38 Shareholder Litigation 38 & Korsinsky LLP 38 Intelek plc 38 Marketing Authorization 38 Form #c# 38 Share Repurchases 38 Marketing Authorisation 38 Boosts Buyback 38 Koosharem Corporation 38 Biomerge 38 Increases Share Repurchase 38 Revised Recommended 38 TSX RBM OTCBB 38 Minimum Bid Price 38 Announces Shareholder Approval 38 Announces Record Date 38 Utiba Americas joint venture 38 Aloxi Injection 38 Financing Commitment 38 Orphan Drug designation 38 Nasdaq Listing Qualifications 38 Recommends Shareholders 38 Sanvar R 38 Director Exercises Options 38 Exchange Offer Documents 38 PRNewswire FirstCall Valeant Pharmaceuticals 38 Declares Quarterly Dividends 38 LVB Acquisition Merger Sub 38 Directors Declares Dividend 38 Overallotment 38 STSPL 38 INDICATED HIGHER 38 Acquire Remaining 38 Gina Talamona spokeswoman 38 Zero Coupon Convertible Subordinated 38 Announces Termination 38 Delned 38 Posts Narrower 4Q Loss 38 Indenture 38 BRILINTA 38 Fiduciary Duties 37 Files Preliminary Proxy 37 CIP TRAMADOL ER 37 Files Quarterly Report 37 Amex VTG NYSE Amex 37 Basic Subscription Privilege 37 Amends Terms 37 promote ceftobiprole 37 Announces Effective Date 37 website www.nyandcompany.com 37 Solicitation Recommendation Statement 37 Buyout Offer 37 NASDAQ NCST 37 dba Vitro Biopharma 37 TSX VENTURE NLI 37 Universal Shelf Registration 37 WINNIPEG MANITOBA #/#/# 37 Biologics License Application BLA 37 Brokered Placement 37 consent solicitation 37 VBV 37 Completes Restructuring 37 Second Amended 37 SouthFirst Bancshares Inc. 37 NYSE BGH 37 ticker symbol UAUA 37 Signs Non Binding 37 Takeover Rules 37 OPE LGI Inc. 37 QuaTech 37 Fund Repurchase Offer 37 Pamrapo Bancorp 37 Reports Receipt 37 DIP Facility 37 ZTEST Announces 37 Stockholder Meeting 37 developing PAMs 37 Honeywell Consumables Solutions 37 risks associatedwith 37 NASDAQ Listing Rule 37 Second Supplemental Indenture 37 NASDAQ GTIV 37 discloseable transaction 37 Letter Agreement 37 Tracy Schmaler 37 HopFed 37 Recommends Acceptance 37 Q4 Profit Soars 37 ESML Intressenter AB 37 Inc. Nasdaq TRMS 37 Shareholders Approve Sale 37 Mary Fran Faraji 37 NASDAQ Listing Qualification 37 Costa Brava Partnership 37 Nasdaq MBRK 37 sNDAs 37 NaturalNano filings 37 Enters Definitive Agreement 37 Inc. OTCBB AHOM 37 Ideation Acquisition Corp. 37 Announces Proposed Settlement 37 Taufers 37 Sets Record Date 37 Norcraft Companies LP 37 NASDAQ LBTYK 37 Tripp Levy PLLC 37 Expiration Date 37 Biologic License Application BLA 37 Inc. NASDAQ CEGE 37 Final Approval 37 Paragraph IV certifications 37 NV Organon 37 strategic alternatives 37 BRL.N Quote Profile Research 37 Sweetens Bid 37 Approves XM Sirius 37 non waivable 37 Clopay Acquisition 37 integrating ADVO operations 37 NYSE SKO 37 Marketing Authorization Application 37 Maximum Tender Offer Expiration 37 Amends Existing 37 Comision Federal de Competencia 37 Nycomed GmbH 37 AdMedia Partners Advises 37 Q4 Loss Narrows 37 Acquire Remaining Shares 37 Bairnco Corporation 37 New Drug Application 37 Q1 Loss Narrows 37 Through Glycoscience ® 37 Q2 Loss Narrows 37 Staff Determination Letter 37 Q3 Profit Surges 37 Application MAA 37 Deregister 37 restate financials 37 TSX VENTURE KWG KWG 37 Receives Anticipated 37 indenture amendments 37 Offering Memorandum dated 37 NASDAQ CTLM 37 CanElson 37 Settles Litigation 37 Fund TSX CHW.UN 37 Implementation Agreement 37 Fast Track designation 37 Approves Merger 37 Orphan Drug Status 37 TSX OBP 37 Creditor Protection 37 Rule #a 8 37 Inc. PINKSHEETS RELM 37 Offer Expiration Date 37 Whitewash Waiver 37 Tender Offer Statement 37 Mutual Recognition Procedure 37 Stock Repurchase 37 Sets Quarterly Dividend 37 ENTIRETY BECAUSE THEY CONTAIN 37 Stock Purchase Agreements 37 plc LSE SHP 37 Default Status Report 37 Commitment Letter 37 ANDA approvals 37 Signs Definitive Merger Agreement 37 IsoTis stockholders 37 Hakon Invest 37 CMI Entities 37 PROMUS Element Stent System 37 consummated 37 Submits Biologics License Application 37 EPE unitholders 37 incense blending 37 Stock Repurchase Program 37 Shareholder Proposals 37 Nasdaq Listing Rule 37 SEBI SAST Regulations 37 NASDAQ OSCI 37 Stalking Horse Bid 37 Announce Termination 37 viii inability 37 Share Issuance 37 Bundeskartellamt 37 Notes tendered 37 ALICO Holdings 37 AGA Medical stockholders 37 AMEX PUDA 37 SVP Exercises Options 37 Consent Deadline 37 FCC PTCRB 37 supplemental indentures effecting 37 Permitted Bid provisions 37 Complete Response letter 37 gastrointestinal disorders ATI 37 suspensive conditions 37 Frontino Acquisition 37 Submits Response 37 Fancamp Announces 37 website www.transmontaignepartners.com 37 fiduciary duties 37 Barr ANDA 37 XLNT Veterinary Care 37 Amended Option Agreement 37 Partnership NASDAQ BBEP 37 Final Settlement Date 37 Proposed Offering 37 acquire ThyroTest ® 37 Freewest solicitation 37 NASDAQ TARG 37 Announces Definitive Agreement 37 Kaboose trades 37 About PhotoChannel Founded 37 Altivity Packaging LLC 37 Certara 37 disinterested shareholder 37 Option Deed 37 CFO Exercises Options 37 Be Acquired 37 Receives Subpoena 37 DIP Financing Facility 37 share repurchase authorizations 37 Files Shelf Registration 37 Advises Stockholders 37 NASDAQ OATS 37 endedDecember 37 commonstock 37 Considers Sale 37 Rule #b 37 NASDAQ DNBK 37 validly withdrawn prior 37 Drug Applications ANDAs 37 BreitBurn GP LLC 37 SMSC Transaction 37 spokeswoman Gina Talamona 37 Primedex 37 Signs Definitive 37 :/ finance.yahoo.com q 37 Cadbury plc 37 hoFH 37 Incorporated URSA Major 37 DGCL 37 TSX LGI 37 Q2 Loss Widens 37 FIRB 37 Amends Merger Agreement 37 Completes Recapitalization 37 SISA Notes 37 Withdrawal Date 37 Wire Wager 37 Wintraysan 37 Microtune stockholders 37 Announces Spin Off 37 Proxy Proposals 37 notes validly tendered 37 Corp. MVSN 37 ArPetrol Transaction 37 TSX PFB 37 validly revoked 37 GLASSIA 37 Zenpep 37 Sinks Lower 37 PCS Affiliate 37 Maximum Tender Offer 37 outstanding indebtedness 37 bookrunning managers 37 Conditions Precedent 37 Merger Proposal 37 Jimmy'Z stores 37 Million Convertible Debt 37 Data Domain stockholders 37 Nasdaq IRSN 37 Shares Popped What 37 Early Participation 37 definitive proxy 37 NYSE BIP 37 Scheme Document 37 Warner Chilcott Limited 37 Merger dated 37 applicable Offering Memorandum 37 Platinum Merger Sub 37 NASDAQ Listing Rules 37 Completes Merger 37 generic Lipitor 37 Miraculins Announces 37 IntelliPharmaCeutics Ltd. 37 Schedules Earnings 37 Nitram Energy 37 NASDAQ ENSI 37 DIP Loan 37 DTLL 37 LITITZ Pa. BUSINESS WIRE 37 KPE unitholders 37 Reorganization Plan 37 GSR Bid 37 stockholders 37 Files Definitive Proxy 37 Staphylococcus aureus Immune Globulin 37 AMEX ISV 37 sBLA 37 Distributor Agreement 37 SVLF 37 Contingent Value Rights 37 Reverse Takeover 37 www.shamrockstocks.com About 37 iMedicor OTCBB VMCI 37 wholly owned immunotherapeutic 37 Bairnco 37 Acquisition BV 37 SIFT Rules 37 GENCO Distribution System 37 ESML Intressenter 37 Announces Dismissal 37 FTC 37 Stock Buyback Program 37 Exchangeco 37 ZYPS 37 Oracea ® 37 Listings Qualifications Panel 37 ThaiLin Semiconductor Corp. 37 indentures governing 37 NYSE Amex PTN 37 Announces Tender Offers 37 Advises Shareholders 37 Tendered Notes 37 Gentex Declares Quarterly 36 Remain Listed 36 subsidiaries Medicsight PLC 36 Sverica International 36 PentaStaph 36 Agreement constitutes discloseable 36 Stockholders Vote 36 Preliminary Proxy 36 Corporation NASDAQ QRCP 36 liver resection surgeries 36 Approves Stock Buyback 36 Fronteer Offer 36 Angiotech Entities 36 Accelerated Feasibility Study 36 Gerdau S.A. 36 stockholders definitive proxy 36 validly delivered 36 Resale Registration Statement 36 Deerfield Triarc 36 Marketing Authorization Application MAA 36 CHLP 36 Signs Definitive Purchase Agreement 36 Bellus Health 36 Partial Tender Offer 36 Listing Qualifications Staff 36 Deregistration 36 OTCBB ORHI 36 NASDAQ LGND 36 PRNewswire FirstCall Warner Chilcott 36 Corporation NASDAQ WEDC 36 shares issuable upon 36 Fundamental Change 36 Guides FY# Earnings 36 Standstill Period 36 Proposed Reorganization 36 CORTOSS Bone Augmentation Material 36 nasdaq OATS news 36 Q4 Loss Widens 36 EPIX Pharmaceuticals 36 Q3 Loss Narrows 36 TASE CAMT 36 Interim Required Filings 36 Kind Tender Offer 36 Acquire Assets 36 Google Permissions 36 repurchase authorization 36 PharmaBio 36 NASDAQ PBCI 36 Q1 Loss Widens 36 Oracea TM 36 Unsolicited Acquisition 36 Aloprim TM allopurinol sodium 36 Form #F 36 Nasdaq CCBP 36 NASDAQ RHIE 36 Changes Ticker Symbol 36 SwissINSO SA 36 Forbearance Agreement 36 Value Creation Plan 36 delisting proceedings